Incident user cohorts for assessing medication cost-offsets

Health Services Research

Volumn 49, Issue 4, 2014, Pages 1364-1386

  Stuart, Bruce ^a   Loh, F Ellen ^a   Roberto, Pamela ^b   Miller, Laura ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b Pharmaceutical Research and Manufacturers of America   (United States)

^c National Association of Chain Drug Stores   (United States)

Author keywords

cost offsets; Drug initiator design; statins

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONFOUNDING VARIABLE; CONTROLLED STUDY; COST CONTROL; DIABETES MELLITUS; DRUG COST; DRUG EFFICACY; DRUG USE; FEMALE; HEALTH INSURANCE; HOSPITALIZATION COST; HUMAN; HYPERLIPIDEMIA; MALE; MEDICATION COMPLIANCE; PROPENSITY SCORE; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

COST-OFFSETS; DRUG INITIATOR DESIGN; STATINS;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; COST SAVINGS; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICARE PART A; MEDICARE PART B; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROPENSITY SCORE; RESEARCH DESIGN; UNITED STATES;

EID: 84905008424     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12170     Document Type: Article

References (44)

1. Abbas, S., P. Ihle, I. Koster, and, I. Schubert,. 2012. " Estimation of Disease Incidence in Claims Data Dependent on the Length of Follow-Up: A Methodological Approach." Health Services Research 47 (2): 746-55.
2. Almuti, K., R. Rimawi, D. Spevack, and, R. Ostfeld,. 2005. " Effects of Statins beyond Lipid Lowering: Potential for Clinical Benefits." International Journal of Cardiology 109 (1): 7-15.
3. American Diabetes Association. 2008. " Standards of Medical Care in Diabetes." Diabetes Care 31 (Suppl 1): S12-54.
4. Andrade, S. E., K. H. Kahler, and, F. Frech,. 2006. " Methods for Evaluation of Medication Adherence and Persistence Using Automated Databases." Pharmacoepideology and Drug Safety 15 (8): 565-74. (Pubitemid 44336271)
5. Aubert, R. E., J. Yao, F. Xia, and, S. B. Garavaglia,. 2012. " Is There a Relationship between Early Statin Compliance and a Reduction in Healthcare Utilization? " The American Journal of Managed Care 16 (6): 459-66.
6. Benner, J. S., R. J. Glynn, H. Mogun, P. J. Neumann, M. C. Weinstein, and, J. Avorn,. 2002. " Long Term Persistence of Statin Therapy in Elderly Patients." Journal of the American Medical Association 288 (4): 455-61. (Pubitemid 34787476)
7. Briesacher, B. A., S. E. Andrade, R. A. Yood, and, K. H. Kahler,. 2007. " Consequences of Poor Compliance with Bisphosphonates." Bone 41 (5): 882-7. (Pubitemid 47593009)
8. Brookhart, M. A., A. R. Patrick, C. Dormuth, J. Avorn, W. Shrank, S. M. Cadarette, and, D. H. Solomon,. 2007. " Adherence to Lipid-Lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect." American Journal of Epidemiology 166 (3): 348-54. (Pubitemid 47216808)
9. Concato, J., N. Shah, and, R. I. Horwitz,. 2000. " Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs." New England Journal of Medicine 342: 187-1892.
10. Congressional Budget Office. 2012. " Offsetting Effects of Prescription Drug Use on Medicare's Spending for Medical Services " [accessed on December 11, 2012]. Available at http://www.cbo.gov/sites/default/ files/cbofiles/attachments/43741-MedicalOffsets-11-29-12.pdf
11. DiMatteo, M. R., P. J. Giordani, H. S. Lepper, and, T. W. Croghan,. 2002. " Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis." Medical Care 40 (9): 794-811.
12. Esposito, D., A. D. Bagchi, J. M. Verdier, D. S. Bencio, and, M. S. Kim,. 2009. " Medicaid Beneficiaries with Congestive Heart Failure: Association of Medication Adherence with Healthcare Use and Costs." The American Journal of Managed Care 15 (7): 437-45.
13. Glynn, R. J., S. Schneeweiss, and, T. Sturmer,. 2006. " Indications for Propensity Scores and Review of Their Use in Pharmacoepidemiology." Basic & Clinical Pharmacology & Toxicology 98 (3): 253-9.
14. Hayward, R., D. Kent, S. Vijan, and, T. Hofer,. 2005. " Reporting Clinical Trial Results to Inform Providers, Payers, and Consumers." Health Affairs 24 (6): 1571-81.
15. Humphrey, L. L., B. K. S. Chan, and, H. C. Sox,. 2002. " Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease." Annals of Internal Medicine 137 (4): 273-84.
16. International Society for Pharmacoeconomics and Outcomes Research [ISPOR]. 2012. ISPOR Good Practices for Outcomes Research [accessed on November 28, 2012]. Available at http://www.ispor.org/workpaper/practices-index.asp
17. Ioannidis, P., 2005. " Contradicted and Initially Stronger Effects in Highly Cited Clinical Research." Journal of the American Medical Association 294 (2): 218-28.
18. Ioannidis, P., 2013. " Are Mortality Differences Detected by Administrative Data Reliable and Actionable? " Journal of the American Medical Association 309 (13): 1410-1.
19. Ioannidis, P., A. Haidich, M. Pappa, N. Pantazis, S. I. Kokori, M. G. Tektonidou, D. G. Contopoulo-Ioannidis, and, J. Lau,. 2001. " Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies." Journal of the American Medical Association 286 (7): 821-30. (Pubitemid 33015576)
20. Johnson, E. S., B. A. Bartman, B. A. Briesacher, N. S. Fleming, T. Gerhard, C. J. Kornegay, P. Nourjah, B. Sauer, G. T. Schumock, A. Sedrakyan, T. Stuermer, S. L. West, and, S. Schneeweiss,. 2012. Effective Health Care Program Research Reports, No. 32. The Incident User Design in Comparative Effective Research. Rockville, MD: AHRQ.
21. Karter, A. J., M. M. Parker, H. H. Moffet, A. T. Ahmed, J. A. Schmittdiel, and, J. V. Selby,. 2009. " New Prescription Medication Gaps: A Comprehensive Measure of Adherence to New Prescriptions." Health Services Research 44 (5): 1640-61.
22. Leiter, L., 2005. " The Prevention of Diabetic Microvascular Complications of Diabetes: Is There a Role for Lipid Lowering? " Diabetes Research and Clinical Practice 68S (2): S3-14. (Pubitemid 40812349)
23. Motheral, B., J. Brooks, M. A. Clark, W. Crown, P. Davey, D. Hutchins, B. C. Martin, and, P. Stang,. 2003. " A Checklist for Retrospective Database Studies -Report of the ISPOR Task Force on Retrospective Databases." Value in Health 6 (2): 90-7. (Pubitemid 36403125)
24. Osterberg, L., and, T. Blaschle,. 2005. " Adherence to Medication." New England Journal of Medicine 353 (5): 487-97. (Pubitemid 41127293)
25. Owens, D. K., K. N. Lohr, D. Atkins, J. R. Treadwell, J.T. Reston, E.B. Bass, S. Chang, and, M. Helfand,. 2009. Methods Guide for Comparative Effectiveness Research: Grading the Strengths of a Body of Evidence When Comparing Medical Interventions. Rockville, MD: AHRQ.
26. Pittman, D. G., W. Chen, S. J. Bowlin, and, J. A. M. Foody,. 2011. " Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations." The American Journal of Cardiology 107 (11): 1662-6.
27. Ray, W. A., 2003. " Evaluating Medication Effects Outside of Clinical Trials: New-User Designs." American Journal of Epidemiology 158 (9): 915-20. (Pubitemid 37323253)
28. Ross, S. D., I. E. Allem, J. E. Connelly, B. M. Korenblat, M. E. Smith, D. Bishop, and, D. Luo, 1999. " Clinical Outcomes in Statin Treatment Trials: A Meta Analysis." Archives of Internal Medicine 159 (15): 1793-802. (Pubitemid 29379144)
29. Rothwell, P., 1995. " Can Overall Results of Clinical Trials Be Applied to All Patients? " Lancet 345 (8965): 1616-9.
30. Rothwell, P., 2005. " External Validity of Randomised Controlled Trials: 'To Whom Do the Results of This Trial Apply?." Lancet 365 (9453): 82-93. (Pubitemid 40082150)
31. Salas, M., D. Hughes, A. Zuluaga, K. Vardeva, and, M. Lebmeier,. 2009. " Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature." Value in Health 12 (6): 915-22.
32. Schneeweiss, S., A. R. Patrick, T. Sturmer, M. A. Brookhart, J. Avorn, M. Maclure, K. J. Rothman, and, R. J. Glynn,. 2007. " Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison with Randomized Trial Results." Medical Care 45 (10 Suppl 2): S131-42.
33. Shadish, W. R., T. D. Cook, and, D. T. Campbell,. 2002. Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Chicago, IL: Wadsworth Publishers.
34. Shang, B., and, D. P. Goldman,. 2007. Prescription Drug Coverage and Elderly Medicare Spending. NBER Working Paper No. 13358. Cambridge, MA: NBER.
35. Sinzinger, H., R. Wolfram, and, B. Peskar,. 2002. " Muscular Side Effects of Statins." Journal of Cardiovascular Pharmacology 40 (2): 163-71. (Pubitemid 34793153)
36. Sokol, M. C., K. A. McGuigan, R. R. Verbrugge, and, R. S. Epstein,. 2005. " Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost." Medical Care 43 (6): 521-30. (Pubitemid 40847288)
37. Solomon, D. H., J. A. Rassen, R. J. Glynn, J. Lee, R. Levin, and, S. Schneeweiss,. 2010. " The Comparative Safety of Analgesics in Older Adults with Arthritis." Archives of Internal Medicine 170 (22): 1968-78.
38. Stuart, B. C., A. Davidoff, R. Lopert, T. Shaffer, J. S. Shoemaker, and, J. Lloyd,. 2011. " Does Medication Adherence Lower Medicare Spending among Beneficiaries with Diabetes? " Health Services Research 46 (4): 1180-99.
39. Stuart, B., F. E. Loh, L. Miller, and, P. Roberto,. 2014. " Should Eligibility for Medication Therapy Management Be Based on Drug Adherence? " Journal of Managed Care Pharmacy 20 (1): 66-75.
40. Tsiara, S., M. Elisaf, and, D. Mikhailidid,. 2003. " Early Vascular Benefits of Statin Therapy." Current Medical Research and Opinion 19 (6): 540-56. (Pubitemid 37122048)
41. Wang, J., and, P. T. Donnan,. 2001. " Propensity Score Methods in Drug Safety Studies: Practice, Strengths, and Limitations." Pharmacoepidemiology and Drug Safety 10 (4): 341-4. (Pubitemid 33040854)
42. Weitzen, A., K. L. Lapane, A. Y. Toledano, A. L. Hume, and, V. Mor,. 2004. " Principles for Modeling Propensity Scores in Medical Research: A Systematic Literature Review." Pharmacoepidemiology and Drug Safely 13 (12): 841-53. (Pubitemid 40003819)
43. World Health Organization. 2003. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO.
44. Zhang, Y., J. M. Donohue, J. R. Lave, G. O'Donnell, and, J. P. Newhouse,. 2009. " The Effect of Medicare Part D on Drug and Medical Spending." New England Journal of Medicine 361 (1): 52-61.